Evaluation of serological lateral flow assays for severe acute respiratory syndrome coronavirus-2

Overview of attention for article published in BMC Infectious Diseases, June 2021

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (57th percentile)
Above-average Attention Score compared to outputs of the same age and source (56th percentile)

Mentioned by

twitter: 5 X users

Citations

dimensions_citation: 25 Dimensions

Readers on

mendeley: 91 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 5 X posts from 5 X users, with an upper bound of 6,862 followers.

RT @SaraSuliman13: Our @MGBCCI evaluation of 20 #SARSCoV2 serological LFAs by @b__trombetta et al is out in #BMCInfectiousDiseases. Incredi…

20 Jun 2021

Reply Repost Favourite

Lateral flow tests have up to 94.6% sensitivity (for Biohit IgG+IgM) and may have an important role in self screening post exposure to COVID and I suspect will play an important role in re opening of schools #COVID19 https://t.co/x8UXZJeRIl

19 Jun 2021

Reply Repost Favourite

RT @SaraSuliman13: Our @MGBCCI evaluation of 20 #SARSCoV2 serological LFAs by @b__trombetta et al is out in #BMCInfectiousDiseases. Incredi…

18 Jun 2021

Reply Repost Favourite

Our @MGBCCI evaluation of 20 #SARSCoV2 serological LFAs by @b__trombetta et al is out in #BMCInfectiousDiseases. Incredible effort from volunteers across the @MassGenBrigham community. https://t.co/LrFuyrYRhJ Thoughts on the future of serological testing f

18 Jun 2021

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 1 additional X posts.